Chapter 29 Avatrombopag abroad—price reduction!
The news that Tsingshan Pharmaceutical's "ITG Human Myelopoietin" is about to launch clinical trials soon appeared on the website of the State Food and Drug Administration, and the first people to notice it were the major domestic pharmaceutical companies.
The major pharmaceutical companies were surprised, and they breathed a sigh of relief when they saw that this was only an auxiliary treatment drug.
That is, it would be okay if every drug was a first-line drug.
What are first-line drugs? What are complementary medicines?
To put it simply,
For example, if you are accidentally infected with influenza A one day, the doctor will generally recommend that you take "oseltamivir" together with some other drugs, such as Lianhua Qingwen and antiviral granules. Perform combined therapy.
Oseltamivir is a specific drug specially used to treat influenza A, and it is the first-line drug.
As for Lianhua Qingwen, antiviral granules, etc., even if you switch to vitamin C and isatis root, it will not affect the treatment effect. These are auxiliary drugs.
Therefore, auxiliary drugs are highly substitutable, and their competitiveness is not even the slightest bit worse than first-line drugs!
Many pharmaceutical companies are completely relieved that it is just an auxiliary drug for the treatment of aplastic anemia and is not a cause for concern.
In the following week, "ITG human myelopoietin" did not make much movement as Feng Gang said. Due to the lack of attractiveness of the treatment, even the first batch of 15 No human patient recruitment has been completed.
Zhang Yang is not in a hurry.
Firstly, this was something he expected. Secondly, at this time, all his energy was focused on the third clinical phase of "Qingshan Avatrombopag".
……
Compared with the slow clinical recruitment of "ITG human genin", "Qingshan Avatrombopag Tablets" can be said to be extremely smooth.
In addition to recruiting 465 subjects in the first month, the efficiency continued unabated in the next two weeks. The remaining more than 200 places were quickly filled by chemotherapy patients, liver disease patients, etc. Patients are waiting to be sold out.
On the 46th day of recruitment, with the successful enrollment of the last trial group, the Phase III clinical recruitment of "Avatrombopag" officially ended.
Zhang Yang immediately announced the news.
As soon as the news came out, the entire pharmaceutical industry was quite surprised.
You know, why does the Phase III clinical trial of an innovative drug often take as long as 3-5 years?
This is because in addition to the constant adjustment of drug ingredients during the clinical process, it also takes an extremely long time to recruit patients.
Normally, the 700-person trial can be completed within one year, which is good, but now!
46 days?
Domestic pharmaceutical companies are shocked, but they have to admit that this is indeed because "Qingshan Avatrombopag Tablets" is so effective, and only in this way can it attract so many patients to join crazily.
While everyone was still immersed in surprise, just a few days later, a sudden news appeared on the Chinese Internet.
Three years after entering the Chinese market, the price of "Avatrombopag Tablets" developed by the American company AkaRx has been reduced.
On JD Pharmacy, the price of AkaRx’s “Avatrombopag Tablets” has been reduced from 7,800 yuan per box to 6,900 yuan per box, a price reduction of 900 yuan.
The news spread quickly, and the first people to notice it were the cancer patients who needed to take "Avatrombopag Tablets" for a long time.
Compared with traditional treatment options for blood patients, there is also the previous generation thrombopoietin "Eltrombopag" to choose from,
Cancer patients, especially those undergoing long-term chemotherapy, have very limited options.
Chemotherapy, in addition to killing cancer cells, will also significantly kill other normal cells in the human body.
So chemotherapy patients almost all suffer from hair loss and almost all suffer from "low platelet disease".
In order for the body to continue to meet the standards of chemotherapy, many indicators such as platelets need to be rapidly increased during chemotherapy.
Traditional platelet-raising drugs are too slow to take effect. "Eltrombopag" has severe side effects on liver and kidney function, making chemotherapy patients almost unbearable. The only option is to have almost no side effects and very effective treatment. Good "Avatrombopag Tablets".
Magic City, in a ward of a cancer hospital.
“Oh, good news, good news, Brother Zhou and Lao Yang, come over and take a look, the price of ‘Avatrombopag’ has been reduced!”
The speaker’s name is Xiao Qiang, 30 He is a stage III lung cancer patient and has been receiving chemotherapy for more than 3 months.
The people he called Brother Zhou and Lao Yang were also lung cancer patients.
"Reduced? Xiao Xiao, don't be ridiculous, I just bought a box outside yesterday morning, it was still 7800, why is it reduced?"
It was Lao Yang who spoke.
At this moment, Brother Zhou on the side also said:
"Xiao Xiao, 'Avatrombopag' has been in the country for two or three years. When did you see its price drop? Not to mention price cuts, pharmacies were still out of stock last month , I’m grateful if it doesn’t increase the price!”
“Hey! If you don’t believe it, come and see for yourself, it’s really reduced!” “It’s really reduced at Jingdong Pharmacy!”
Listening to Xiao Qiang's words of assurance, Brother Zhou and Lao Yang came over with doubts. When they saw it, their faces were full of surprise!
“Damn it, the price has actually been reduced!”
“Yes, this is the first time in the world. Could it be that conscience has discovered it?”
“Conscience Found?”
Xiao Qiang couldn’t help but smile bitterly:
"Brother Zhou, do you believe him or do you believe I am Qin Shihuang? How can this group of pharmaceutical companies find out with conscience?"
"Don't talk about this drug, all foreign targeted drugs and imported drugs, what do you think? Have you ever seen them lower their prices?”
The two couldn’t help but nodded.
"Why did the price suddenly drop?"
At this moment, the three people's eyes fell on the press release on their mobile phones.
After a while, the three of them raised their heads with some disbelief in their eyes.
“I remember this company, Qingshan Pharmaceutical. Their ‘Qingshan Avatrombopag’ made a lot of noise some time ago. I didn’t expect that they really made foreign pharmaceutical companies feel the pressure!”
< br>Brother Zhou couldn’t help but take a deep breath, his face full of solemnity!
"Lao Yang, you said before that domestically produced drugs must not be very effective. Now it seems that we must thank Qingshan Pharmaceutical!"
"If nothing else, just reduce the price. 900 yuan is what they saved for us!”
Lao Yang nodded heavily and murmured:
"Qingshan Pharmaceutical!"
The news not only spread in the tumor ward, but also quickly spread to blood patients and liver disease patients. group, all patients know an answer in their hearts.
The price reduction is not due to the conscience of foreign pharmaceutical companies, but because they feel pressure.
The source of pressure is none other than Tsingshan Pharmaceutical, "Tsingshan Avatrombopag Tablets".
...
At five-thirty in the afternoon, it’s time to get off work.
In the office of the hematologist at the Third People's Hospital of Chengdu, Director Hu looked at the screen of his mobile phone and couldn't help but smile.
After a while, another deputy chief physician, Ren Xiaoyang, walked into the office.
Director Hu called out to Ren Xiaoyang.
"Professor Ren, let's have a drink together after get off work."
Ren Xiaoyang's face was full of surprise and he was completely confused.
"Director, don't you usually drink?"
Director Hu smiled slightly, then pointed to the screen of his mobile phone gently:
"Watch the news."
"I'm so happy today, I made an exception!"
"Happy?"
Ren Xiaoyang quickly glanced at his phone, and what he saw was a huge title.
[Avatrombopag Tablets, a subsidiary of AkaRx, has faced pressure from domestic new drugs and has been reduced in price for the first time in China. 】
He was stunned for two seconds, and suddenly a sudden surge of excitement rushed straight to his forehead.
"Director, I will accompany you!"
(End of this chapter)